Opus Genetics, Inc. (IRD)

Opus Genetics Statistics

Total Valuation

Opus Genetics has a market cap or net worth of $295.61 million. The enterprise value is $225.42 million.

Market Cap	295.61M
Enterprise Value	225.42M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Opus Genetics has 71.40 million shares outstanding. The number of shares has increased by 159.75% in one year.

Current Share Class	71.40M
Shares Outstanding	71.40M
Shares Change (YoY)	+159.75%
Shares Change (QoQ)	+7.83%
Owned by Insiders (%)	7.27%
Owned by Institutions (%)	46.86%
Float	50.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.72
Forward PS	18.31
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	18.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.13

Current Ratio	7.13
Quick Ratio	6.71
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.04

Financial Efficiency

Return on equity (ROE) is -7,594.60% and return on invested capital (ROIC) is -1,340.12%.

Return on Equity (ROE)	-7,594.60%
Return on Assets (ROA)	-46.79%
Return on Invested Capital (ROIC)	-1,340.12%
Return on Capital Employed (ROCE)	-74.91%
Weighted Average Cost of Capital (WACC)	8.09%
Revenue Per Employee	$427,964
Profits Per Employee	-$3.82M
Employee Count	28
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +292.16% in the last 52 weeks. The beta is 0.63, so Opus Genetics's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+292.16%
50-Day Moving Average	4.92
200-Day Moving Average	2.93
Relative Strength Index (RSI)	31.23
Average Volume (20 Days)	937,233

Short Selling Information

The latest short interest is 2.00 million, so 2.80% of the outstanding shares have been sold short.

Short Interest	2.00M
Short Previous Month	1.81M
Short % of Shares Out	2.80%
Short % of Float	3.97%
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, Opus Genetics had revenue of $11.98 million and -$106.93 million in losses. Loss per share was -$1.42.

Revenue	11.98M
Gross Profit	-18.83M
Operating Income	-43.03M
Pretax Income	-106.93M
Net Income	-106.93M
EBITDA	-42.98M
EBIT	-43.03M
Loss Per Share	-$1.42

Balance Sheet

The company has $59.96 million in cash and $1.20 million in debt, with a net cash position of $58.76 million or $0.82 per share.

Cash & Cash Equivalents	59.96M
Total Debt	1.20M
Net Cash	58.76M
Net Cash Per Share	$0.82
Equity (Book Value)	-21.10M
Book Value Per Share	-0.64
Working Capital	57.26M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	53,250
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-157.13%
Operating Margin	-359.13%
Pretax Margin	-892.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Opus Genetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-159.75%
Shareholder Yield	-159.75%
Earnings Yield	-37.63%
FCF Yield	n/a

Analyst Forecast

The average price target for Opus Genetics is $10.13, which is 144.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.13
Price Target Difference	144.69%
Analyst Consensus	Strong Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	53.66%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1